Measured Wealth Private Client Group, LLC Catalent, Inc. Transaction History

Measured Wealth Private Client Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$47.45 - $58.05 $478,296 - $585,144	-10,080 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$39.26 - $54.21 $34,745 - $47,975	-885 Reduced 8.07%	10,080 $546,000
Q1 2019 May 07, 2019	BUY	$29.84 - $43.92 $90,713 - $133,516	3,040 Added 38.36%	10,965 $445,000
Q4 2018 Feb 07, 2019	SELL	$29.95 - $46.34 $92,695 - $143,422	-3,095 Reduced 28.09%	7,925 $247,000
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $9,829 - $11,159	245 Added 2.27%	11,020 $504,000
Q2 2018 Aug 14, 2018	BUY	$38.72 - $42.52 $417,208 - $458,153	10,775 New	10,775 $451,000

512

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.6B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.